Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 329

Results For "LA"

10664 News Found

Yashoda Hospitals opens world-class Biplane Neuro Cath lab for brain stroke
Hospitals | October 29, 2021

Yashoda Hospitals opens world-class Biplane Neuro Cath lab for brain stroke

It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology


Mandaviya launches the sixth edition of National Formulary of India (NFI)
Public Health | October 29, 2021

Mandaviya launches the sixth edition of National Formulary of India (NFI)

The NFI is published to promote the rational use of medicines in the country.


Oasis Fertility forays into Karnataka plans 10 more centres
Hospitals | October 28, 2021

Oasis Fertility forays into Karnataka plans 10 more centres

It plans to double its network to 50 centres across India in the next three years


Sun Pharma introduces treatment for plaque psoriasis in Canada
Drug Approval | October 28, 2021

Sun Pharma introduces treatment for plaque psoriasis in Canada

Moderate-to-severe plaque psoriasis affects about 35 per cent of patients. A key challenge is that many treatments stop working overtime and symptoms return


Honeywell launches real-time health monitoring system
Digitisation | October 28, 2021

Honeywell launches real-time health monitoring system

Combination of hardware and data analytics software improves real-time and remote patient monitoring; digitizes and automates time-consuming and critical tasks for medical personnel, reducing administrative tasks by 35 per cent


Cipla consolidated net profit at Rs 711.36 cr. in Q2FY22
News | October 27, 2021

Cipla consolidated net profit at Rs 711.36 cr. in Q2FY22

Cipla has reported consolidated financial results for the period ended September 30, 2021


Dr Lal PathLabs to acquire Suburban Diagnostics for Rs 925 crore
Clinical Trials | October 27, 2021

Dr Lal PathLabs to acquire Suburban Diagnostics for Rs 925 crore

Dr Lal PathLabs revenue contribution from west India to go up from 10% to 24% post-acquisition basis FY21


Glenmark launches novel fixed-dose combination for diabetes
Drug Approval | October 26, 2021

Glenmark launches novel fixed-dose combination for diabetes

It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination


PM launches PM Ayushman Bharat Health Infrastructure Mission
Public Health | October 26, 2021

PM launches PM Ayushman Bharat Health Infrastructure Mission

Through the mission an entire ecosystem for services from treatment to critical research will be created in every corner of the country


Roche’s Susvimo, for `wet’ age-related macular degeneration (nAMD) approved
Drug Approval | October 25, 2021

Roche’s Susvimo, for `wet’ age-related macular degeneration (nAMD) approved

The implant is surgically inserted into the eye during a one-time, outpatient procedure and refilled every six months